NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
5.91
+0.02 (0.34%)
At close: Aug 25, 2026, 4:00 PM EDT
5.91
0.00 (-0.07%)
After-hours: Aug 25, 2026, 7:30 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $27.05 million as of August 25, 2026. Its market cap has increased by 97.05% in one year.
Market Cap
27.05M
Enterprise Value
11.63M
1-Year Change
97.05%
Ranking
Category
Stock Price
$5.91
ChartMarket Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $27.05M, a decrease of -93.80%. That is a compound annual growth rate of -31.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 27.05M | -45.62% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 31.09M |
| Kyntra Bio | 30.45M |
| Actuate Therapeutics | 30.39M |
| NanoViricides | 30.30M |
| Lantern Pharma | 29.91M |
| Genenta Science | 29.72M |
| BeyondSpring | 29.61M |
| Tevogen | 28.48M |